Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Meads: What is the cost of blindness?. (0.11 sec) 

What is the cost of blindness?

- nih.gov
C Meads, C Hyde - British journal of Ophthalmology, 2003 - bjo.bmj.com
Age related macular degeneration (AMD), particularly the wet variant, is an
important cause of blindness and a serious public health challenge in older
people. A recent health technology appraisal for the National Institute for ...
Cited by 27 - Related articles - BL Direct - All 6 versions

Direct costs of blindness in Australia


SE Wright, JE Keeffe, LS Thies - Clinical and Experimental Ophthalmology, 2000 - interscience.wiley.com
This study calculated the direct financial costs of blindness to the Australian
government and community. Three case studies, representative of Australians with
severely impaired vision, were used to calculate the annual costs ...
Cited by 35 - Related articles - BL Direct - All 3 versions

[CITATION] Hyde C. What is the cost of blindness


C Meads - Br J Ophthalmol, 2003
Cited by 2 - Related articles

Cheaper can be better: cutting costs and improving low vision aid service


A Landers, J Tapley, B Billington, V Almgill, A … - British Journal of Visual Impairment, 1999 - jvi.sagepub.com
Hospital Eye Service Prescription forms is expensive and often associated with
poor patient satisfaction as found in the studies by Mcllwaine, Bell and Dutton
(1 991) and by Humphrey and Thompson (1986). We audited this service in a ...
Cited by 4 - Related articles - BL Direct

Recent trends in visual impairment and blindness in the UK

- fetalneonatal.com
F Bodeau-Livinec, G Surman, M Kaminski, AR … - Archives of Disease in Childhood, 2007 - fetalneonatal.com
Results: Of 691 eligible children, 358 (53%) had VI and 323 (47%) SVI/BL. The
cumulative incidence of VI to age 12 years was 7.1 (95% CI 6.4 to 7.8) per 10
000 live births and for SVI/BL was 6.2 (95% CI 5.6 to 6.9); the incidence ...
Cited by 5 - Related articles - BL Direct - All 5 versions

The economic burden of global blindness: a price too high!

- nih.gov [PDF] 
AF Smith, JG Smith - The British Journal of Ophthalmology, 1996 - pubmedcentral.nih.gov
The World Health Organisation defines blindness as a best corrected visual
acuity of less than 3/60.1 Using this definition it is estimated that there are
currently 37 9 million blind people (1-4 million children 0-15 years of ...
Cited by 38 - Related articles - BL Direct - All 6 versions

A revolution in Welsh low vision service provision

- bmj.com [PDF] 
TH Margrain, B Ryan, JM Wild - British Medical Journal, 2005 - bjo.bmj.com
C ataract is the leading cause of blindness in the world, 1 and the leading
cause of low vision in European derived populations. 2 The burden of cataract is
likely to increase as the world's population ages. 2 At present, no ...
Cited by 7 - Related articles - BL Direct - All 9 versions

Methods for measuring personal costs associated with vision impairment


SL Chou, E Lamoureux, J Keeffe - Ophthalmic epidemiology, 2006 - informahealthcare.com
Purpose: To describe and evaluate the procedures used to collect personal costs
associated with vision impairment using diaries. Methods: Participants with
impaired vision (VA < 6/12 or ≥ 6/12 with restricted visual fields) were ...
Cited by 7 - Related articles - BL Direct - All 6 versions

Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with …


N Bansback, S Davis, J Brazier - Eye, 2006 - nature.com
A health economic model is used to synthesise the evidence on contrast
sensitivity and treatment rates from the TAP Investigation with health state
utilities and costs. Impairment of visual function is estimated using a ...
Cited by 11 - Related articles - BL Direct - All 3 versions

Cost of glaucoma in Canada: analyses based on visual field and physician's assessment


M Iskedjian, J Walker, C Vicente, GE Trope, Y … - Journal of Glaucoma, 2003 - journals.lww.com
From the PharmIdeas Research and Consulting Inc. (Mr Iskedjian and Vicente, and
Drs Walker and Einarson); Brock University Faculty of Business (Dr Walker);
Department of Ophthalmology, University of Toronto (Drs Trope and Buys); ...
Cited by 25 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google